Sort
82,697 grants matching “vaccine development”
PPG: SARS-CoV-host cell interactions and vaccine development
$1,599,714Stanley Perlman · University Of Iowa · P01 · FY2011 · AI
Cell Production Core Facility
$1,599,337Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Surgery Branch Cell Prep Core
$1,599,337Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES)
$1,599,082Eva Harris · University Of California Berkeley · U01 · FY2020 · AI
DEVELOPMENT OF SAPONIN DMLT ADJUVANT (SDA)
$1,598,870Elizabeth Norton · Tulane University Of Louisiana · N01 · FY2024 · AI
CLINICAL DEVELOPMENT OF THE PFSPZ VACCINE TO PROTECT THE WARFIGHTER FROM MALARIA
$1,597,439Sanaria Inc. · · FY2014 · Department of Defense
Units for HIV/AIDS Clinical Trials Networks
$1,597,142Michael C Keefer · University Of Rochester · UM1 · FY2013 · AI
Computational Biology and Biostatistics Core
$1,596,937Bette T. Korb · Duke University · U19 · FY2007 · AI
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,596,752Marina Caskey · Rockefeller University · U01 · FY2023 · AI
T Cell Immune Responses To HIV And Other Pathogens
$1,596,278Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Testing of Blood Samples for Immune Response and Vaccine Research
$1,596,277Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Active Immune Therapy and HAART for HIV-1 Infection
$1,596,146University Of Pennsylvania · U19 · FY2004 · AI
Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells
$1,596,110Carl H. June · University Of Pennsylvania · U19 · FY2013 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,595,796Stanley Perlman · University Of Iowa · P01 · FY2014 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,595,795Stanley Perlman · University Of Iowa · P01 · FY2015 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,595,795Stanley Perlman · University Of Iowa · P01 · FY2012 · AI
Nanoparticle-based development for HIV-1 biomolecule delivery
$1,595,794Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2021 · AI
Immune Reconstitution
$1,595,731Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Core--Vector
$1,595,516Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2007 · AI
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses
$1,594,895Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Transition to Human Phase 1b Trials: Nonclinical Studies of an Anti-METH mAb
$1,594,873Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2015 · DA
Aging and Immunity to Infections
$1,593,959Susan L Swain · Trudeau Institute, Inc. · P01 · FY2006 · AG
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,593,930Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Strategies for Cancer Immunotherapy Clinical Trials
$1,593,930Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Prevention of AIDS
$1,593,708Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA